The 7th APS International PharmSci 2016
05 September 2016 - 07 September 2016
5-7 September 2016 will see the 7th APS International PharmSci Conference moving to the newly-opened Technology & Innovation Centre at the University of Strathclyde, Glasgow. The conference will follow in Scotland’s rich heritage in the Sciences, Mathematics and Technology which has left a proud trail of famous scientists to inspire and encourage others to follow in their footsteps. The theme of the conference in 2016 is 'Pharmaceutical Sciences: Improving World Health'.
Technology and Innovation Centre, University of Strathclyde, Glasgow, UK
https://www.ukpharmsci.org/
11th Drug Design & Medicinal Chemistry Conference
12 September 2016 - 13 September 2016
This meeting will provide a forum for scientists across multiple disciplines, from both industry and academia, to connect and share complementary perspectives. We will discuss emerging target classes, advances in antibody drug conjugates and other methods for targeted drug delivery, new approaches in flow chemistry, and much more. In addition to scientific presentations, we will have dedicated times for networking among delegates.
Session topics include:
I. Advances in Addressing Traditional and New Target Classes
II. Targeting Protein-Protein Interactions
III. Methods for Target Identification
IV. New Opportunities for Computational Drug Design
V. Big Data in Medicinal Chemistry
Hyatt Boston Harbour, Boston, MA, USA
https://www.gtcbio.com/conferences/medicinal-chemistry-drug-design-overview?utm_source=11ddmc&utm_medium=eventlisting&utm_campaign=overview
4th GPCR in Drug Discovery Conference
14 September 2016 - 15 September 2016
The landscape for drug discovery has changed drastically over the past few years: private and public partnerships are changing how research is being done, researchers are using 3D model systems in hopes of improving clinical outcomes, and emerging target classes are changing traditional conceptions of the drug discovery process.
Leaders in the field will share about advances in topics such as GPCRs in diseases, approaches to GPCR signaling, and biased signaling. Join us as we discuss basic biology to translational research in the field of GPCRs and gather for dedicated networking sessions with colleagues from academia and industry.
Session Topics:
GPCR Chemical Biology & Novel Molecular Probes
Allosteric Modulators & Biased Signaling
GPCR Signaling Pathways & Mechanisms
GPCR Structure & Dynamics
GPCR in Disease
Hyatt Boston Harbour, Boston, MA, USA
https://www.gtcbio.com/conferences/gpcr-drug-discovery-overview
7th Non-Coding RNA & RNAi Therapeutics Conference
14 September 2016 - 15 September 2016
Emerging areas in RNA research provide great insight into promising therapeutic tools. Delivery has remained a solid focus for understanding how RNA has proven to play a vital and central role in all cellular function. Advances in cell selective delivery and the target abilities of RNAi demonstrate growth and maturity in the field. The excitement and interest that CRISPR brings continues to progress the evolution of genome editing tools. We will also dive into application of aptamers in diagnostic and therapeutic settings. This will include stability, affinity and specificity of oligonucleotide aptamer ligands and other delivery approaches as well.
This meeting will create space for researchers to learn about the latest discoveries in the field, as well as share and discuss perspectives during networking sessions.
Session topics include:
I. CRISPR Mediated Genome Editing and Functional Screening
II. Emerging Applications for Non-Coding RNAs in Basic and Clinical Research
III. Therapeutic Delivery of Nucleic Acid-Based Drugs
IV. Advances in RNAi, Antisense, and Non-Coding RNA-Based Drugs in Clinical Development
Hyatt Boston Harbour, Boston, MA, USA
https://www.gtcbio.com/conferences/non-coding-rna-rnai-therapeutics-overview?utm_source=Event%20Listing&utm_medium=7RNA&utm_campaign=overview
Genetic Insider
14 September 2016 - 15 September 2016
: More than 20 expert speakers and 130 senior attendees will be at the first commercially focused congress for the diagnostics industry. There, we will discuss the route to unlock Personalized Medicine through companion diagnostics.
The 14-15 Sept you’ll learn about trends, new business models, the latest regulatory affairs, ways to increase demand, market access and reimbursement. Join of Caris LifeSciences, Faegre BD, Eugenomic, Paralax Life Sciences, the Personalized Medicine Coalition and many more to go deeper in the industry’s biggest challenges.
Catalonia Eixample 1864, Barcelona, Spain
http://genetic-insider.com/diagnostics/
SMi’s 5th Annual Conference: Cancer Vaccines
21 September 2016 - 22 September 2016
Aimed at an audience of senior scientists and oncology specialists involved in targeted vaccines and drug research, Cancer Vaccines 2016 will provide a perfect platform to discuss pioneering clinical developments and the next generation of cancer immunotherapy. The 5th annual show will capture expert insight by honing in on new pathways with novel vaccines and immunotherapies, drug formulations, personalised treatment, immune check-point inhibitors, plus more
Join us this September for strategic direction on vaccine commercialisation and arm yourself with the key requirements and tools for successful vaccine development through informed guidance delivered by a top panel of speakers including Vaccinogen Inc, MSD, Genentech, Northwest Biotherapeutics, and more!
Holiday Inn Kensington Forum, London, UK
https://www.smi-online.co.uk/pharmaceuticals/uk/cancer-vaccines?utm_medium=www.cancervaccinesevent.com&utm_source=P-183&utm_campaign=ddt
SMi’s 7th Annual Conference: Biosimilars Europe
29 September 2016 - 30 September 2016
SMi Group is thrilled to present the 7th annual conference, Biosimilars Europe , taking place on 29th & 30th September 2016 in Central London, UK. Gathering an audience of principle scientists and regulatory experts involved in biotechnology and compliance, Biosimilars Europe 2016 will provide a perfect platform to discuss global market developments and strategies to market access.
Created with a top panel of industry thought leaders, this year's event will capture expert insight by honing in on the biosimilar product life-cycle from early stage developments, protein characterisation, and pricing & reimbursement; through to emerging markets and global developments.
Join us this autumn to arm yourself with the key requirements and tools for successful market entry through strategic direction on commercialisation; insight into potential therapeutic areas; and guidance on product quality assessment (PQA) in biosimilar development. The notable speaker line-up includes: Boehringer Ingelhei, Merck, Lupin Ltd, Bristows, Austrian Agency for Health and Food Safety + many more!
Holiday Inn Kensington Forum, London, UK
https://www.smi-online.co.uk/pharmaceuticals/uk/biosimilars-europe?utm_medium=www.biosimilars-europe.com&utm_source=P-184&utm_campaign=ddt